Lorente, L.; Martín, M.M.; Abreu-González, P.; Sabatel, R.; Ramos, L.; Argueso, M.; Solé-Violán, J.; Cáceres, J.J.; Jiménez, A.; García-Marín, V.
Higher Serum Melatonin Levels during the First Week of Malignant Middle Cerebral Artery Infarction in Non-Surviving Patients. Brain Sci. 2019, 9, 346.
https://doi.org/10.3390/brainsci9120346
AMA Style
Lorente L, Martín MM, Abreu-González P, Sabatel R, Ramos L, Argueso M, Solé-Violán J, Cáceres JJ, Jiménez A, García-Marín V.
Higher Serum Melatonin Levels during the First Week of Malignant Middle Cerebral Artery Infarction in Non-Surviving Patients. Brain Sciences. 2019; 9(12):346.
https://doi.org/10.3390/brainsci9120346
Chicago/Turabian Style
Lorente, Leonardo, María M. Martín, Pedro Abreu-González, Rafael Sabatel, Luis Ramos, Mónica Argueso, Jordi Solé-Violán, Juan J. Cáceres, Alejandro Jiménez, and Victor García-Marín.
2019. "Higher Serum Melatonin Levels during the First Week of Malignant Middle Cerebral Artery Infarction in Non-Surviving Patients" Brain Sciences 9, no. 12: 346.
https://doi.org/10.3390/brainsci9120346
APA Style
Lorente, L., Martín, M. M., Abreu-González, P., Sabatel, R., Ramos, L., Argueso, M., Solé-Violán, J., Cáceres, J. J., Jiménez, A., & García-Marín, V.
(2019). Higher Serum Melatonin Levels during the First Week of Malignant Middle Cerebral Artery Infarction in Non-Surviving Patients. Brain Sciences, 9(12), 346.
https://doi.org/10.3390/brainsci9120346